JAKK:NASDAQJAKKS Pacific, Inc. Analysis
Data as of 2026-04-11 - not real-time
$21.82
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
JAKKS Pacific is trading above its short‑ and long‑term moving averages, and the MACD indicator has turned bullish, suggesting continued upward momentum. The RSI sits in the upper half of its range, reinforcing the strength of the current trend while still leaving room for further upside. Beta is notably high, indicating that price swings are amplified relative to the broader market, and the 30‑day volatility is elevated, which raises the risk profile. Volume has been on a downtrend, signaling waning participation that could limit the durability of the rally.
Fundamentally, the stock appears overvalued, with a discounted cash‑flow estimate far below the market price and a forward earnings multiple that implies limited growth expectations. Revenue is contracting and operating margins are negative, while free cash flow remains in the red, casting doubt on the sustainability of the generous dividend, whose payout exceeds earnings. The consumer‑cyclical sector exposes the company to economic swings, and the recent maximum drawdown highlights vulnerability during market stress.
Fundamentally, the stock appears overvalued, with a discounted cash‑flow estimate far below the market price and a forward earnings multiple that implies limited growth expectations. Revenue is contracting and operating margins are negative, while free cash flow remains in the red, casting doubt on the sustainability of the generous dividend, whose payout exceeds earnings. The consumer‑cyclical sector exposes the company to economic swings, and the recent maximum drawdown highlights vulnerability during market stress.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish technical alignment (price above SMAs, MACD bullish)
- Elevated beta and volatility increasing price risk
- Dividend payout ratio above 100% raising sustainability concerns
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Potential upside relative to analyst price targets
- Weak fundamentals (negative revenue growth, operating losses)
- Decreasing trading volume limiting market depth
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Significant overvaluation versus DCF fair value
- Sustained negative cash flow and margins
- High sensitivity to consumer‑cyclical downturns
Key Metrics & Analysis
Financial Health
Revenue Growth-2.80%
Profit Margin1.73%
P/E Ratio25.4
ROE4.03%
ROA2.00%
Debt/Equity21.42
P/B Ratio1.0
Op. Cash Flow$8.5M
Free Cash Flow$-4910125
Technical Analysis
TrendBullish
RSI64.9
Support$19.11
Resistance$22.34
MA 20$20.32
MA 50$19.93
MA 200$18.49
MACDBullish
VolumeDecreasing
Fear & Greed Index87.09
Valuation
Fair Value$6.93
Target Price$28.50
Upside/Downside30.61%
GradeOvervalued
TypeValue
Dividend Yield4.58%
Risk Assessment
Beta1.78
Volatility29.23%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.